Richard Bernstein Advisors’s CVS Health CVS Stock Holding History

Richard Bernstein Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,718	Closed	-$1.33M	–	235
2025 Q4	$1.33M	Sell	16,718 -1,844	-10%	-$145K	0.04%	111
2025 Q3	$1.4M	Sell	18,562 -19,373	-51%	-$1.33M	0.04%	140
2025 Q2	$2.62M	Buy	+37,935	New	+$2.49M	0.06%	157
2023 Q3	–	Sell	-34,308	Closed	-$2.37M	–	217
2023 Q2	$2.37M	Hold	34,308	–	–	0.05%	136
2023 Q1	$2.55M	Hold	34,308	–	–	0.05%	141
2022 Q4	$3.2M	Hold	34,308	–	–	0.07%	118
2022 Q3	$3.27M	Sell	34,308 -5,711	-14%	-$565K	0.08%	115
2022 Q2	$3.71M	Hold	40,019	–	–	0.08%	123
2022 Q1	$4.05M	Hold	40,019	–	–	0.08%	129
2021 Q4	$4.13M	Buy	40,019 +29,619	+285%	+$2.74M	0.08%	120
2021 Q3	$882K	Hold	10,400	–	–	0.02%	268
2021 Q2	$867K	Hold	10,400	–	–	0.02%	265
2021 Q1	$782K	Sell	10,400 -73,533	-88%	-$5.36M	0.02%	275
2020 Q4	$5.73M	Hold	83,933	–	–	0.14%	67
2020 Q3	$4.9M	Hold	83,933	–	–	0.14%	70
2020 Q2	$5.45M	Sell	83,933 -22,274	-21%	-$1.4M	0.17%	58
2020 Q1	$6.3M	Sell	106,207 -9,705	-8%	-$648K	0.22%	41
2019 Q4	$8.61M	Hold	115,912	–	–	0.28%	38
2019 Q3	$7.31M	Hold	115,912	–	–	0.24%	46
2019 Q2	$6.32M	Hold	115,912	–	–	0.21%	63
2019 Q1	$6.25M	Buy	115,912 +67,352	+139%	+$4.16M	0.2%	77
2018 Q4	$3.18M	Hold	48,560	–	–	0.12%	179
2018 Q3	$3.82M	Buy	+48,560	New	+$3.47M	0.11%	208
2018 Q1	–	Sell	-8,391	Closed	-$608K	–	328
2017 Q4	$608K	Hold	8,391	–	–	0.03%	198
2017 Q3	$682K	Hold	8,391	–	–	0.05%	184
2017 Q2	$675K	Hold	8,391	–	–	0.05%	175
2017 Q1	$659K	Hold	8,391	–	–	0.05%	197
2016 Q4	$662K	Hold	8,391	–	–	0.06%	199
2016 Q3	$747K	Hold	8,391	–	–	0.07%	191
2016 Q2	$803K	Hold	8,391	–	–	0.08%	228
2016 Q1	$870K	Sell	8,391 -72,978	-90%	-$7.1M	0.09%	229
2015 Q4	$7.96M	Hold	81,369	–	–	1.02%	20
2015 Q3	$7.85M	Hold	81,369	–	–	1.07%	14
2015 Q2	$8.53M	Buy	81,369 +6,644	+9%	+$679K	1.03%	13
2015 Q1	$7.71M	Hold	74,725	–	–	1.01%	15
2014 Q4	$7.2M	Hold	74,725	–	–	0.74%	26
2014 Q3	$5.95M	Hold	74,725	–	–	0.63%	46
2014 Q2	$5.63M	Hold	74,725	–	–	0.66%	40
2014 Q1	$5.59M	Buy	74,725 +39,027	+109%	+$2.76M	0.79%	25
2013 Q4	$2.56M	Buy	35,698 +3,413	+11%	+$219K	0.52%	55
2013 Q3	$1.83M	Hold	32,285	–	–	0.54%	42
2013 Q2	$1.85M	Buy	+32,285	New	+$1.87M	0.61%	34

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Richard Bernstein Advisors's CVS Position: Q1 2026 in Review

Richard Bernstein Advisors sold out of CVS Health (CVS) in Q1 2026, closing a stake of 16,718 shares — an estimated $1.33M sold.

Richard Bernstein Advisors first reported a position in CVS in Q2 2013 and held it in 42 quarters. The position peaked at $8.61M in Q4 2019. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Richard Bernstein Advisors reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Richard Bernstein Advisors sold 16,718 CVS Health shares in Q1 2026, an estimated $1.33M.
Richard Bernstein Advisors first reported a position in CVS Health in Q2 2013 and held it in 42 quarters.
Richard Bernstein Advisors's CVS Health position peaked at $8.61M in Q4 2019.
1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Richard Bernstein Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.